Author:
Mosessian Sherly,Duarte-Vogel Sandra M.,Stout David B.,Roos Kenneth P.,Lawson Gregory W.,Jordan Maria C.,Ogden Amanda,Matter Cheryl,Sadeghi Saman,Mills George Q.,Schelbert Heinrich R.,Radu Caius G.,Czernin Johannes,Couto Marcelo,Phelps Michael E.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology
Reference24 articles.
1. Vallabhajosula S, Solnes L, Vallabhajosula B (2011) A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new? Semin Nucl Med 41:246–264
2. Harapanhalli RS (2010) Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals. Semin Nucl Med 40:364–384
3. Final rule (21 CFR part 212): (2009) current good manufacturing practice for positron emission tomography drugs Fed Regist 74 (236),65409–65436
4. Guidance on current good manufacturing practice for positron emission tomography (2009) Fed Regist; 74 (236),65538–65539
5. Guidance for small business entities on current good manufacturing practice for positron emission tomography drugs; availability (2011) Fed Regist; 76 (151),47593–47594
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献